DHL’s Nijmegen campus is FDA approved; California facility is QEP accredited

DHL Supply Chain’s contract manufacturing operation at its Life Sciences & Healthcare Campus in Nijmegen, The Netherlands, has successfully undertaken two Good Manufacturing Practice (GMP) audits, one with the US Food & Drug Administration (FDA), the second with the Brazilian FDA ANVISA.

According to Arjen Hellinga, business development manager at DHL Supply Chain in The Netherlands, this approval is unique for a logistics provider. It allows a number of products to go through ‘late stage customisation‘ – including kitting and labelling – at DHL’s facility, prior to being exported to markets outside the EU such as the US and Brazil.

At its shared-use Pharma Grade campus in Nijmegen, DHL manages supply chains for more than 25 pharmaceutical and medical device companies.

In other news, DHL’s Brisbane, California station (near San Francisco) has received accreditation as a Qualified Envirotainer Provider (QEP).

The company expects the San Juan station and several other North America stations to be added to its portfolio of QEP Accredited stations by the end of 2011.

Envirotainer launched its QEP/ CEP Training and Quality Program at the request of shippers of healthcare products and in response to industry guidance. The program acknowledges those service providers capable of properly managing shipments using Envirotainer containers. It confirms providers meet their obligations as defined in the current Good Distribution Practices guidance documents, including the requirements of the Parenteral Drug Association (PDA) and the International Air Transport Association (IATA).

According to Mark McGonegal, vice president, West Region at  DHL Global Forwarding, the company plans to further invest in making its DHL Brisbane Station a Life Science Competency Centre in the coming year. The facility will include cold storage for deep frozen, controlled 2 ° – 8 ° Celsius and controlled 15 ° – 25 ° Celsius, all high in demand for pharmaceutical and biotechnology customers.

DHL currently has a total of seventeen dedicated Life Science Competency Centres designed to provide a global network of dedicated people, customised processes, and a quality controlled environment specifically for shipping of pharmaceutical, biotech and medical devices.

Quelle: eyefortransport
Portal:  www.logistik-express.com

 

Ähnliche Beiträge

Schreibe einen Kommentar